RECRUITING

Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Background: \- Biomarkers are substances in people s blood and tissues. They help researchers understand diseases and signs of aging. Scientists want to do more research on biomarkers to find ways to improve quality of life in old age. Objective: \- To learn more about biomarkers and their relationship to aging. Eligibility: \- Adults at least 20 years old who weigh at least 110 pounds and have a body mass index below 30. They must agree that their genetic samples can be collected, studied, and stored. Design: * Participants will be screened with medical history, physical exam, EKG and blood and urine tests. * Participants will have 3-day visits. They will return every 2 years. * All visits include: * Blood and urine collection * Physical performance tests * Health questionnaires * Memory and problem-solving tests * Magnetic Resonance Imaging (MRI) and Computerized Tomography (CT) scans. * Muscle metabolism/ exercise tests * Taste strips * Muscle and/or skin biopsies/ red light therapy * Retinal imaging/ eye tracking * Sleep study * ODD visits also include: * Cytapheresis * Bone marrow aspirate * EVEN visits also include: * Hyperglycemic CLAMP * Lumbar Puncture (LP) * Continuous Glucose Monitor (CGM)

Official Title

The Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)

Quick Facts

Study Start:2015-03-15
Study Completion:2099-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02339012

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 120 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Linda M Zukley, Ph.D.
CONTACT
(410) 350-3983
zukleylm@mail.nih.gov
Luigi Ferrucci, M.D.
CONTACT
(410) 558-8110
ferruccilu@grc.nia.nih.gov

Principal Investigator

Luigi Ferrucci, M.D.
PRINCIPAL_INVESTIGATOR
National Institute on Aging (NIA)

Study Locations (Sites)

National Institute of Aging, Clinical Research Unit
Baltimore, Maryland, 21224
United States

Collaborators and Investigators

Sponsor: National Institute on Aging (NIA)

  • Luigi Ferrucci, M.D., PRINCIPAL_INVESTIGATOR, National Institute on Aging (NIA)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-03-15
Study Completion Date2099-12-31

Study Record Updates

Study Start Date2015-03-15
Study Completion Date2099-12-31

Terms related to this study

Keywords Provided by Researchers

  • Genome Wide Association
  • Biomarkers
  • Methylation
  • Phenotype
  • Cytometry
  • Natural History

Additional Relevant MeSH Terms

  • Healthy Volunteers
  • Non-Healthy/Non-Frail
  • Frail